dc.contributor.author |
Malavige, G.N., Premaratne, M.K., Perera, S.S.N., Jayasinghe, S. |
|
dc.date.accessioned |
2018-11-12T06:25:14Z |
|
dc.date.available |
2018-11-12T06:25:14Z |
|
dc.date.issued |
2017-02-15 |
|
dc.identifier.citation |
Malavige, G.N., Premaratne, M.K., Perera, S.S.N., Jayasinghe, S. (2017). "Mathematical Modelling of Immune Parameters in the Evolution of Severe Dengue", Computational and Mathematical Methods in Medicine, pp. 1-9 |
en_US |
dc.identifier.uri |
http://dr.lib.sjp.ac.lk/handle/123456789/7348 |
|
dc.description |
1. Introduction
Sri Lanka has experienced a marked increase in dengue
from 2004 to 2014. The increase from the year 2013 to 2014
was 47.4% (from 32,063 to 47,246) [1]. Although the overall
mortality rate is low, every patient carries the potential risks
of developing dengue hemorrhagic fever (DHF).The current
case fatality is around 0.2–0.3% and early diagnosis and
optimum care should be able to reduce these figures further.
Under these circumstances it would be greatly beneficial if
DHF could be predicted early.
The infection is spread by a mosquito that acts as the
vector for the disease. After entering the body from a bite,
the incubation period lasts for about 4–10 days. Although the
majority of the infected individuals develop asymptomatic
disease, approximately 10% develop symptoms such as high
fever, diarrhea, retroorbital pain, joint and muscle pains, or
more severe forms of clinical disease associated with fluid
leakage [2].
With the symptomatic febrile phase there are changes in
the platelet count, lymphocyte count, NS1 antigen levels, IgG
antibody levels, and other parameters including cytokines
levels. After a variable period (about 3 to 5 days) a minority
of symptomatic patients enter a phase of fluid loss from the
intravascular compartment through capillaries (i.e., called
the “critical phase” to denote its importance in management).
This stage lasts for 48 hours and it is crucial that patient
receive adequate amounts of fluid to counter the fluid leak
during this period. If the degree of severity increases, the
organs of the patient gradually fail resulting in the death of
the patient.
Themediation of fluid leak is through cytokines acting on
the vascular endothelium, and currently there is evidence to
link it to platelet activating factor (PAF) [3].
Hindawi Publishing Corporation
Computational and Mathematical Methods in Medicine
Volume 2017, Article ID 2187390, 9 pages
https://doi.org/10.1155/2017/2187390
2 Computational and Mathematical Methods in Medicine
One marker of severity is the persistence of the dengue
NS1 antigen.This indicates the presence of dengue virus and
its presence during the period of 5-6 days after illness is
associated with more severe disease [4]. Dengue NS1 itself
appears to be associated with vascular leak and triggers the
production of many inflammatory cytokines.
The virus has the ability to destroy platelets and reduce
its production in the marrow thus reducing the platelet
count [5]. Hence the platelet count is a significant marker
in determining the severity of dengue and a count less than
20,000 platelets/mm3 is an indicator of severe dengue [6].
The severity of illness increases depending on whether it
is the primary or the secondary infection, and in the latter
the antibodies developeddue to theprimarydengue infection
stimulate a stronger immune mediated illness (i.e., known
as antibody dependent enhancement) [7]. The changes in
the dengue virus specific IgG reveal whether the patient is
having a secondary or a primary infection. High levels of
dengue virus specific IgG indicate a secondary infection [6].
The lymphocyte indicates how the body is recovering from
the disease. A lymphocyte count below 1,500 cells/mm3 is
associated with more severe stages of dengue [6].
Viral dynamics during primary and secondary infections
has been researched upon [8] and these viral dynamic models
elaborate on the immune response and its dynamics in the
body. However most of the researches focus on the effects
of a single parameter on the severity of dengue. This study
is an attempt to develop a mathematical model based on
the cumulative effects of risks indicated by platelet count,
lymphocyte count, dengue NS1 antigen, and dengue virus
specific IgG levels and other parameters from published data. |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
Hindawi Publishing Corporation |
en_US |
dc.title |
Mathematical Modelling of Immune Parameters in the Evolution of Severe Dengue |
en_US |
dc.title.alternative |
Computational and Mathematical Methods in Medicine |
en_US |
dc.type |
Article |
en_US |
dc.identifier.doi |
10.1155/2017/2187390 |
en_US |